Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Depression with psychotic features is influenced by the polymorphism of the serotonin transporter gene.

Stamm TJ, Stingl J, Wiethoff K, Ricken R, Heinz A, Bauer M, O'Malley G, Adli M.

J Affect Disord. 2013 Nov;151(2):605-10. doi: 10.1016/j.jad.2013.07.005. Epub 2013 Aug 12.

PMID:
23948632
2.

Interaction of 5-HTTLPR genotype and unipolar major depression in the emergence of aggressive/hostile traits.

Gonda X, Fountoulakis KN, Csukly G, Bagdy G, Pap D, Molnár E, Laszik A, Lazary J, Sarosi A, Faludi G, Sasvari-Szekely M, Szekely A, Rihmer Z.

J Affect Disord. 2011 Aug;132(3):432-7. doi: 10.1016/j.jad.2011.03.029. Epub 2011 Apr 13.

PMID:
21492940
3.

Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect?

Baune BT, Hohoff C, Mortensen LS, Deckert J, Arolt V, Domschke K.

Depress Anxiety. 2008;25(11):920-5.

PMID:
18050262
4.

Association of the serotonin transporter gene-linked polymorphic region (5-HTTLPR) genotype with depression in elderly persons after hip fracture.

Lenze EJ, Munin MC, Ferrell RE, Pollock BG, Skidmore E, Lotrich F, Rogers JC, Quear T, Houck P, Reynolds CF 3rd.

Am J Geriatr Psychiatry. 2005 May;13(5):428-32.

PMID:
15879594
5.

Association of serotonin transporter promoter gene polymorphism (5-HTTLPR) with depression in Costa Rican schizophrenic patients.

Contreras J, Hernández S, Quezada P, Dassori A, Walss-Bass C, Escamilla M, Raventos H.

J Neurogenet. 2010 Jul;24(2):83-9. doi: 10.3109/01677060903583994.

PMID:
20397838
6.

Association study of the 5-HTTLPR polymorphism and depression in 75-Year-Old nondemented subjects from the Vienna Transdanube Aging (VITA) study.

Grünblatt E, Löffler C, Zehetmayer S, Jungwirth S, Tragl KH, Riederer P, Fischer P.

J Clin Psychiatry. 2006 Sep;67(9):1373-8.

PMID:
17017823
7.

[Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].

Auxéméry Y.

Encephale. 2012 Oct;38(5):373-80. doi: 10.1016/j.encep.2011.12.003. Epub 2012 Jan 24. Review. French.

PMID:
23062450
8.

Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.

Won ES, Chang HS, Lee HY, Ham BJ, Lee MS.

Neuropsychobiology. 2012;66(4):221-9. doi: 10.1159/000341876. Epub 2012 Oct 20.

PMID:
23095326
9.

The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.

Smits KM, Smits LJ, Peeters FP, Schouten JS, Janssen RG, Smeets HJ, van Os J, Prins MH.

Psychiatr Genet. 2008 Aug;18(4):184-90. doi: 10.1097/YPG.0b013e3283050aca.

PMID:
18628680
10.

No Influence of a functional polymorphism within the serotonin transporter gene on partial sleep deprivation in major depression.

Baghai TC, Schule C, Zwanzger P, Zill P, Ella R, Eser D, Deiml T, Minov C, Rupprecht R, Bondy B.

World J Biol Psychiatry. 2003 Jul;4(3):111-4.

PMID:
12872203
11.

The serotonin transporter gene polymorphism (5-HTTLPR) and affective symptoms among women diagnosed with borderline personality disorder.

Maurex L, Zaboli G, Ohman A, Asberg M, Leopardi R.

Eur Psychiatry. 2010 Jan;25(1):19-25. doi: 10.1016/j.eurpsy.2009.05.001. Epub 2009 Aug 20.

PMID:
19699062
12.

Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele.

Dorado P, Peñas-Lledó EM, González AP, Cáceres MC, Cobaleda J, Llerena A.

Fundam Clin Pharmacol. 2007 Aug;21(4):451-3.

PMID:
17635185
13.

The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression.

Dreimüller N, Tadić A, Dragicevic A, Boland K, Bondy B, Lieb K, Laux G, Maier W, Müller MJ, Rao ML, Rietschel M, Röschke J, Zill P, Hiemke C.

Pharmacopsychiatry. 2012 May;45(3):108-13. doi: 10.1055/s-0031-1291347. Epub 2011 Nov 15.

PMID:
22086748
14.

Serotonin transporter gene (5-HTTLPR) and major psychoses.

Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E.

Mol Psychiatry. 2002;7(1):95-9.

15.

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.

Zanardi R, Serretti A, Rossini D, Franchini L, Cusin C, Lattuada E, Dotoli D, Smeraldi E.

Biol Psychiatry. 2001 Sep 1;50(5):323-30.

PMID:
11543734
16.

Alleles of a functional serotonin transporter promoter polymorphism are associated with major depression in alcoholics.

Nellissery M, Feinn RS, Covault J, Gelernter J, Anton RF, Pettinati H, Moak D, Mueller T, Kranzler HR.

Alcohol Clin Exp Res. 2003 Sep;27(9):1402-8.

PMID:
14506400
17.

Serotonin transporter gene promoter polymorphism and somatoform symptoms.

Hennings A, Zill P, Rief W.

J Clin Psychiatry. 2009 Nov;70(11):1536-9. doi: 10.4088/JCP.08m04613. Epub 2009 Jun 16.

PMID:
19538902
18.

Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?

Illi A, Poutanen O, Setälä-Soikkeli E, Kampman O, Viikki M, Huhtala H, Mononen N, Haraldsson S, Koivisto PA, Leinonen E, Lehtimäki T.

Eur Arch Psychiatry Clin Neurosci. 2011 Mar;261(2):95-102. doi: 10.1007/s00406-010-0126-x. Epub 2010 Jul 17.

PMID:
20640435
19.

The combined effects of the 5-HTTLPR and 5-HTR1A genes modulates the relationship between negative life events and major depressive disorder in a Chinese population.

Zhang K, Xu Q, Xu Y, Yang H, Luo J, Sun Y, Sun N, Wang S, Shen Y.

J Affect Disord. 2009 Apr;114(1-3):224-31. doi: 10.1016/j.jad.2008.07.012. Epub 2008 Oct 9.

PMID:
18848359
20.

A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder.

Willeit M, Praschak-Rieder N, Neumeister A, Zill P, Leisch F, Stastny J, Hilger E, Thierry N, Konstantinidis A, Winkler D, Fuchs K, Sieghart W, Aschauer H, Ackenheil M, Bondy B, Kasper S.

Mol Psychiatry. 2003 Nov;8(11):942-6.

PMID:
14593433

Supplemental Content

Support Center